SYNAGEVA BIOPHARMA CORP (CIK: 0000911326) EDGAR, Information, Filings... CompaniesBIO.Com

SYNAGEVA BIOPHARMA CORP

Mailing address
33 HAYDEN AVE., LEXINGTON, Delaware, 02421
Phone
(781) 357-9900
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

SYNAGEVA BIOPHARMA CORP (CIK: 0000911326) is an American company incorporated in the state of Massachusetts. Head office is located at 33 HAYDEN AVE., LEXINGTON, Massachusetts, 02421. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). SYNAGEVA BIOPHARMA CORP is a public company and trade via Over-The-Counter (OTC).

Old names:

TRIMERIS INC from 1997-01-Oct to 2011-13-Oct

Owner	Filings	Transaction Date	Type of Owner
WIRTH PETER	0001021041	Jun-22-2015	director
ALEXION PHARMACEUTICALS INC	0000899866	Jun-19-2015	10 percent owner
Pulsar Merger Sub Inc	0001642078	Jun-19-2015	10 percent owner
Williams Glen	0001559209	Jun-05-2015	officer: SVP, Technical Operations
Bazemore Robert B	0001620152	Jun-05-2015	officer: Chief Operating Officer
Secor Alicia	0001584516	Aug-12-2013	officer: SVP, Chief Operating Officer
Baker Bros. Advisors (GP) LLC	0001580575	Jul-01-2013	director, 10 percent owner
Glynn Michael	0001528924	Oct-30-2012	officer: SVP Global Business Operations
Baker Brothers Life Sciences LP	0001363364	Jul-13-2012	director
FBB Associates	0001534842	Jul-13-2012	director
Baker Biotech Fund II (A), L.P.	0001551130	Jul-13-2012	director
Baker Bros. Investments II, L.P.	0001551132	Jul-13-2012	director
Baker Bros. Investments, L.P.	0001551136	Jul-13-2012	director
Baker/Tisch Investments, LP	0001551137	Jul-13-2012	director
14159, L.P.	0001551138	Jul-13-2012	director
667, L.P.	0001551139	Jul-13-2012	director
Biggar Stephen R	0001340380	Jun-27-2012	director
BAKER BROS ADVISORS LLC	0001263508	Apr-12-2012	director, 10 percent owner
AKKARAJU SRINIVAS	0001253170	Mar-19-2012	director
TISCH ANDREW H	0001009879	Nov-02-2011	10 percent owner
TISCH JAMES S	0001010178	Nov-02-2011	10 percent owner
TISCH THOMAS J	0001081916	Nov-02-2011	10 percent owner
TISCH DANIEL R	0001111794	Nov-02-2011	10 percent owner
Baker Biotech Capital (GP), LLC	0001244389	Nov-02-2011	director, 10 percent owner
BOESS CARSTEN	0001277495	Nov-02-2011	officer: CFO
Malley Thomas	0001403322	Nov-02-2011	director
Samuels Robyn	0001532120	Nov-02-2011	director
Heberlig Chris	0001532217	Nov-02-2011	officer: Vice President, Finance
Patel Sanj K	0001532218	Nov-02-2011	director, officer: Director and President/CEO
Quinn Anthony	0001532219	Nov-02-2011	officer: SVP, Chief Medical Officer
Grinstead Eric	0001532221	Nov-02-2011	officer: SVP, Commercial Operations
Goldberg Mark Alan	0001532475	Nov-02-2011	director, officer: SVP, Product Dvp & Director
EDELMAN JOSEPH	0001164426	Jul-28-2011	10 percent owner
PERCEPTIVE ADVISORS LLC	0001224962	Jul-28-2011	10 percent owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD	0001249675	Jul-28-2011	10 percent owner
14159 capital (GP), LLC	0001317493	Sep-28-2010	director, 10 percent owner
Thomas James R	0001469932	Aug-12-2009	director
HealthCor Hybrid Offshore GP, LLC	0001454849	Jan-27-2009	director, 10 percent owner
HealthCor Hybrid Offshore Master Fund, L.P.	0001454850	Jan-27-2009	director, 10 percent owner
HealthCor Offshore GP, LLC	0001454852	Jan-27-2009	director, 10 percent owner
HealthCor Offshore Master Fund, L.P.	0001454853	Jan-27-2009	director, 10 percent owner
HEALTHCOR L P	0001337961	Feb-08-2008	10 percent owner
Healey Joseph Patrick	0001343779	Feb-08-2008	director, 10 percent owner
Cohen Arthur Bruce	0001343780	Feb-08-2008	director, 10 percent owner
HealthCor Management, L.P.	0001343781	Feb-08-2008	10 percent owner
HealthCor Offshore, Ltd.	0001354427	Feb-08-2008	10 percent owner
HealthCor Associates, LLC	0001409305	Feb-08-2008	10 percent owner
HealthCor Hybrid Offshore	0001409306	Feb-08-2008	10 percent owner
HealthCor Group, LLC	0001409307	Feb-08-2008	10 percent owner
HealthCor Capital, L.P.	0001409308	Feb-08-2008	10 percent owner
Alrutz Michael A	0001422345	Jan-24-2008	officer: General Counsel
MATTINGLY MARTIN A	0001265782	Nov-14-2007	director, officer: Chief Executive Officer
HealthCor Strategic, LLC	0001413354	Sep-21-2007	10 percent owner
MIGNONE ROBERTO	0001258394	Aug-20-2007	10 percent owner
SWIFTCURRENT PARTNERS	0001118292	Aug-17-2007	10 percent owner
SWIFTCURRENT OFFSHORE LTD	0001124973	Aug-17-2007	10 percent owner
BRIDGER MANAGEMENT LLC	0001166309	Aug-17-2007	10 percent owner
BRIDGER CAPITAL LLC	0001410684	Aug-17-2007	10 percent owner
Graham Andrew L	0001303460	Aug-15-2007	officer: Director of Finance
Ohmstede Carol	0001398631	Aug-15-2007	other: VP of Project Planning
BAKER JULIAN	0001087939	Aug-14-2007	director
BAKER FELIX	0001087940	Aug-14-2007	director
DAVIS STEPHEN	0001131146	Aug-14-2007	director
TANG KEVIN C	0001178579	Aug-14-2007	director
Quart Barry D	0001384243	Aug-14-2007	director
Ratto Daniel	0001398628	Jul-27-2007	officer: Chief Financial Officer
HILL E LAWRENCE JR	0001394435	Mar-15-2007	officer: President and COO
Baker Bros. Capital (GP), LLC	0001244390	Jan-31-2007	director, 10 percent owner
Baker / Tisch Capital (GP), LLC	0001244392	Oct-02-2006	director, 10 percent owner
Baker Biotech Capital II (GP), LLC	0001244386	Apr-25-2006	10 percent owner
Baker Biotech Capital II (Z) (GP), LLC	0001307726	Apr-25-2006	10 percent owner
Baker Brothers Life Sciences Capital (GP), LLC	0001307729	Apr-25-2006	director, 10 percent owner
Baker Biotech Capital II (A) (GP), LLC	0001307727	Oct-13-2004	director, 10 percent owner
Skolsky Steven D	0001300868	Sep-08-2004	director, officer: Chief Executive Officer
Koszalka George W	0001294626	Jun-22-2004	other: EVP of Scientific Operations
LIPTON JEFFREY M	0001011201	Jun-18-2003	director
SANDERS CHARLES A	0001022936	Jun-18-2003	director
COOK GARY	0001183895	Jun-18-2003	director
CROUT J RICHARD	0001183896	Jun-18-2003	director
BOLOGNESI DANI P	0001183900	Jun-18-2003	director, officer: Chief Executive Officer
ELLIS M NIXON	0001183902	Jun-18-2003	officer: President
CREECH TIMOTHY J	0001183898	Jun-02-2003	officer: Vice President of Finance
BONCZEK ROBERT R	0001183901	May-29-2003	officer: CFO and General Counsel

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SYNAGEVA BIOPHARMA CORP

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000858744-16-000037 (34 Act) Size: KB	Feb-16-2016	005-52299 161421372
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-15-245194 (34 Act) Size: KB	Jul-06-2015	000-23155 15972585
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001571049-15-005382 ( Act) Size: 0 KB	Jun-29-2015
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001144204-15-038778 (34 Act) Size: KB	Jun-24-2015	005-52299 15948208
CT ORDER	Document	Acc-no: 9999999997-15-011113 (34 Act) Size: KB	Jun-24-2015	000-23155 15947774
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-15-038750 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-15-038749 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055581 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055580 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055579 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055578 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055577 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055576 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055575 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055574 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055573 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055572 ( Act) Size: 0 KB	Jun-23-2015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-15-055571 ( Act) Size: 0 KB	Jun-23-2015
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-15-231331 (33 Act) Size: KB	Jun-23-2015	333-44145 15946146
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-15-231328 (33 Act) Size: KB	Jun-23-2015	333-44147 15946142

Recent 20 filings. View all SYNAGEVA BIOPHARMA CORP filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

SYNAGEVA BIOPHARMA CORP overview
SYNAGEVA BIOPHARMA CORP job
SYNAGEVA BIOPHARMA CORP stock
SYNAGEVA BIOPHARMA CORP ownership
SYNAGEVA BIOPHARMA CORP CEO
SYNAGEVA BIOPHARMA CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.